BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16981274)

  • 1. Treatment of gastric precancerous lesions with Weiansan.
    Li HZ; Wang H; Wang GQ; Liu J; Zhao SM; Chen J; Song QW; Gao W; Qi XZ; Gao Q
    World J Gastroenterol; 2006 Sep; 12(33):5389-92. PubMed ID: 16981274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. H. pylori eradication prevents the progression of gastric intestinal metaplasia in reflux esophagitis patients using long-term esomeprazole.
    Yang HB; Sheu BS; Wang ST; Cheng HC; Chang WL; Chen WY
    Am J Gastroenterol; 2009 Jul; 104(7):1642-9. PubMed ID: 19436275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Establishment of Mongolian gerbil model of long-term Helicobacter pylori infection].
    Jin Z; Hu FL; Wei H; Tang XY; Dong Y
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(22):1518-22. PubMed ID: 18956630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precancerous conditions after H. pylori eradication: a randomized double blind study in first degree relatives of gastric cancer patients.
    Massarrat S; Haj-Sheykholeslami A; Mohamadkhani A; Zendehdel N; Rakhshani N; Stolte M; Mirzaei M; Saliminejhad M; Saeidi S; Shahidi M
    Arch Iran Med; 2012 Nov; 15(11):664-9. PubMed ID: 23102241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The gastric mucosal protective effects of astragaloside IV in mnng-induced GPL rats.
    Cai T; Zhang C; Zhao Z; Li S; Cai H; Chen X; Cai D; Liu W; Yan Y; Xie K; Pan H; Zeng X
    Biomed Pharmacother; 2018 Aug; 104():291-299. PubMed ID: 29775897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised clinical trial: the effects of Helicobacter pylori eradication on glandular atrophy and intestinal metaplasia after subtotal gastrectomy for gastric cancer.
    Cho SJ; Choi IJ; Kook MC; Yoon H; Park S; Kim CG; Lee JY; Lee JH; Ryu KW; Kim YW
    Aliment Pharmacol Ther; 2013 Sep; 38(5):477-89. PubMed ID: 23822578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wei-fu-chun tablet halted gastric intestinal metaplasia and dysplasia associated with inflammation by regulating the NF-κB pathway.
    Xie D; Wu C; Wang D; Nisma Lena BA; Liu N; Ye G; Sun M
    J Ethnopharmacol; 2024 Jan; 318(Pt B):117020. PubMed ID: 37567428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori infection, glandular atrophy and intestinal metaplasia in superficial gastritis, gastric erosion, erosive gastritis, gastric ulcer and early gastric cancer.
    Zhang C; Yamada N; Wu YL; Wen M; Matsuhisa T; Matsukura N
    World J Gastroenterol; 2005 Feb; 11(6):791-6. PubMed ID: 15682469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions.
    You WC; Brown LM; Zhang L; Li JY; Jin ML; Chang YS; Ma JL; Pan KF; Liu WD; Hu Y; Crystal-Mansour S; Pee D; Blot WJ; Fraumeni JF; Xu GW; Gail MH
    J Natl Cancer Inst; 2006 Jul; 98(14):974-83. PubMed ID: 16849680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].
    Walecka-Kapica E; Knopik-Dabrowicz A; Klupińska G; Chojnacki J
    Pol Merkur Lekarski; 2008 Feb; 24(140):95-100. PubMed ID: 18634262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric precancerous lesions and Helicobacter pylori infection in relatives of gastric cancer patients from Northeastern Brazil.
    Motta CR; Cunha MP; Queiroz DM; Cruz FW; Guerra EJ; Mota RM; Braga LL
    Digestion; 2008; 78(1):3-8. PubMed ID: 18689994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlations among Helicobacter pylori infection and the expression of cyclooxygenase-2 and vascular endothelial growth factor in gastric mucosa with intestinal metaplasia or dysplasia.
    Liu D; He Q; Liu C
    J Gastroenterol Hepatol; 2010 Apr; 25(4):795-9. PubMed ID: 20492336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A correlational study of Weifuchun and its clinical effect on intestinal flora in precancerous lesions of gastric cancer.
    Bian Y; Chen X; Cao H; Xie D; Zhu M; Yuan N; Lu L; Lu B; Wu C; Bahaji Azami NL; Wang Z; Wang H; Zhang Y; Li K; Ye G; Sun M
    Chin Med; 2021 Nov; 16(1):120. PubMed ID: 34801051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.
    Wong BC; Lam SK; Wong WM; Chen JS; Zheng TT; Feng RE; Lai KC; Hu WH; Yuen ST; Leung SY; Fong DY; Ho J; Ching CK; Chen JS;
    JAMA; 2004 Jan; 291(2):187-94. PubMed ID: 14722144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precancerous gastric conditions in high Helicobacter pylori prevalence areas: comparison between Eastern European (Lithuanian, Latvian) and Asian (Taiwanese) patients.
    Jonaitis L; Ivanauskas A; Janciauskas D; Funka K; Sudraba A; Tolmanis I; Krams A; Stirna D; Vanags A; Kupcinskas L; Leja M; Lin JT
    Medicina (Kaunas); 2007; 43(8):623-9. PubMed ID: 17895638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Helicobacter pylori infection and gastric mucosal histological features of gastric ulcer patients with chronic gastritis patients.
    Zhang C; Yamada N; Wu YL; Wen M; Matsuhisa T; Matsukura N
    World J Gastroenterol; 2005 Feb; 11(7):976-81. PubMed ID: 15742399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A five-year follow-up study on the pathological changes of gastric mucosa after H. pylori eradication.
    Zhou L; Sung JJ; Lin S; Jin Z; Ding S; Huang X; Xia Z; Guo H; Liu J; Chao W
    Chin Med J (Engl); 2003 Jan; 116(1):11-4. PubMed ID: 12667379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Helicobacter pylori immunoglobulin G (IgG) and IgA antibody responses and the value of clinical presentations in diagnosis of H. pylori infection in patients with precancerous lesions.
    Li S; Lu AP; Zhang L; Li YD
    World J Gastroenterol; 2003 Apr; 9(4):755-8. PubMed ID: 12679926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori eradication improves gastric atrophy and intestinal metaplasia in long-term observation.
    Kodama M; Murakami K; Okimoto T; Abe T; Nakagawa Y; Mizukami K; Uchida M; Inoue K; Fujioka T
    Digestion; 2012; 85(2):126-30. PubMed ID: 22269293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication.
    Leung WK; Lin SR; Ching JY; To KF; Ng EK; Chan FK; Lau JY; Sung JJ
    Gut; 2004 Sep; 53(9):1244-9. PubMed ID: 15306578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.